These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12608939)

  • 1. The regulation of growth in glycogen storage disease type 1.
    Mundy HR; Hindmarsh PC; Matthews DR; Leonard JV; Lee PJ
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):332-9. PubMed ID: 12608939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The growth hormone-insulin-like growth factor axis in glycogen storage disease type 1: evidence of different growth patterns and insulin-like growth factor levels in patients with glycogen storage disease type 1a and 1b.
    Melis D; Pivonello R; Parenti G; Della Casa R; Salerno M; Balivo F; Piccolo P; Di Somma C; Colao A; Andria G
    J Pediatr; 2010 Apr; 156(4):663-70.e1. PubMed ID: 20022338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
    Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peak and trough growth hormone (GH) concentrations influence growth and serum insulin like growth factor-1 (IGF-1) concentrations in short children.
    Achermann JC; Brook CG; Robinson IC; Matthews DR; Hindmarsh PC
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):301-8. PubMed ID: 10435054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
    Savage MO; Blum WF; Ranke MB; Postel-Vinay MC; Cotterill AM; Hall K; Chatelain PG; Preece MA; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1465-71. PubMed ID: 7505286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.
    Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth in children with craniopharyngioma following surgery.
    Tiulpakov AN; Mazerkina NA; Brook CG; Hindmarsh PC; Peterkova VA; Gorelyshev SK
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):733-8. PubMed ID: 10209560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
    Rogol AD; Blethen SL; Sy JP; Veldhuis JD
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):229-37. PubMed ID: 12580940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of growth failure and partial reversal with gene therapy in murine and canine Glycogen Storage Disease type Ia.
    Brooks ED; Little D; Arumugam R; Sun B; Curtis S; Demaster A; Maranzano M; Jackson MW; Kishnani P; Freemark MS; Koeberl DD
    Mol Genet Metab; 2013 Jun; 109(2):161-70. PubMed ID: 23623482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease.
    Wolfsdorf JI; Crigler JF
    J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):136-43. PubMed ID: 10435649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.
    Bouhours-Nouet N; Gatelais F; Boux de Casson F; Rouleau S; Coutant R
    J Clin Endocrinol Metab; 2007 Feb; 92(2):629-35. PubMed ID: 17090643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
    Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone treatment of short Chinese children with beta-thalassaemia major without GH deficiency.
    Low LC; Kwan EY; Lim YJ; Lee AC; Tam CF; Lam KS
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):359-63. PubMed ID: 7750189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.
    Cohen P; Rogol AD; Howard CP; Bright GM; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2480-6. PubMed ID: 17356043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Wit JM; Wolff ED; de Jong MC; Donckerwolcke RA; Abbad NC; Bot A; Blum WF
    Lancet; 1991 Sep; 338(8767):585-90. PubMed ID: 1715501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth and endocrine changes in the hepatic glycogenoses.
    Dunger DB; Holder AT; Leonard JV; Okae J; Preece MA
    Eur J Pediatr; 1982 May; 138(3):226-30. PubMed ID: 6749505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.